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Prosthetic cardiac valve replacement
To the Editor:
The US Food and Drug Administration
(FDA) has become aware of a problem
associated with cardiac valve prosthetic re-
placement arising from mismatch between
annulus sizing devices and the labeled di-
mension of prostheses. Anecdotal reports
suggest that discrepancies between the la-
beled size of prostheses and the dimensions
of the specific sizer may have compro-
mised seating of selected valve prosthe-
ses.1 Christakis and colleagues2 docu-
mented discrepancies of as much as 8 mm
between the labeled size of a particular
prosthesis and the external diameter of the
sewing cuff. Considerable variation was
also found between the diameters of sew-
ing cuffs for valves labeled as similar in
size by different manufacturers. Although
these discrepancies may not in themselves
be relevant to the implantation procedure
when the appropriately matched device-
specific sizer is used, the use of generic or
so-called universal sizers or of sizers de-
signed for other prostheses, even if from
the same manufacturer, may result in se-
lection of an oversized valve. At best such
an occurrence will require discarding a de-
vice before suture attachment because of
body fluid contamination. A more serious
consequence occurs when the mismatch is
not recognized until the attempt to seat the
prosthesis after suture placement.
To assess the pervasiveness of this
problem with valve sizers, the Society of
Thoracic Surgeons, in cooperation with the
FDA, surveyed a cohort of 200 cardiac
surgeons. One hundred six responders to a
mailed questionnaire identified problems
with manufacturer-supplied sizers in 31 in-
stances and with universal sizers in 7 cases.
The responders also indicated knowledge
of similar problems experienced by other
surgeons in 52 instances.
The intention of this communication is
to alert surgeons to the FDA’s concerns
regarding the problem of valve and sizer
mismatch. The frequency of occurrence
suggests a need for remedial prosthetic la-
beling that accurately and uniformly across
devices describes both sewing cuff external
dimensions and orifice area. Tight manu-
facturing controls should ensure that the
prosthetic sewing cuff dimension matches
the labeled size within specified tolerances
that provide confidence that they are accu-
rately reflected by the sizers used to mea-
sure the cardiac valve annulus.
Because of the FDA’s concerns, sur-
geons are cautioned to use only sizers la-
beled for use with the specific prosthetic
valve to be implanted. In addition, it is
advised that selection of a satisfactory de-
vice fit be confirmed by testing the pros-
thesis within the annulus before insertion
of sewing cuff sutures.
Bram D. Zuckerman, MD
Wolf Sapirstein, MD
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Division of Cardiovascular Devices
Rockville, MD 20850
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Resection of pulmonary
arteriovenous fistula
To the Editor:
The article on pulmonary arteriovenous fis-
tula by Schro¨der and colleagues1 was of
interest to me, as was the follow-up Letter
to the Editor by Fell.2
I have treated a number of patients with
pulmonary arteriovenous fistulas through
the years, including in particular a family
congenitally affected for 4 generations. Ini-
tially, in the early 1970s, I performed pri-
mary resection of the fistulous lesions with-
out removal of additional lung tissue.
The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 6 1563
Before stapling devices, arteriovenous fis-
tulas would be sutured and resected. When
staplers became available, I was able to
isolate and resect the arteriovenous fistulas
with good results. Arteriovenous fistulas
the size of an apple or larger (7-8 cm) may
be excised without the removal of normally
functioning pulmonary tissue with this
technique.
The lesions, which may be multiple and
bilateral, are relatively easy to delineate
and dissect in preparation for removal. I
have not used anticoagulation and have not
had any difficulty with embolism. Most
such patient concerns have been suspected
as a result of routine chest radiography and
follow-up with computed tomography. The
results of magnetic resonance imaging, as
compared with contrast angiography, will
be interesting in the future. Currently I first
consider embolization, especially when the
lesions are small, multiple, and bilateral. If
the lesion is large or the catheter technique
is not desired, I proceed to resection. I
understand that in most cases embolic ther-
apy is preferred at this time; however, there
is still a place for primary resection of the
large or coincidentally found lesion. Such a
resection may be performed with a pulmo-
nary-sparing technique.
Raymond A. Dieter, Jr, MD
The Center for Surgery
General Surgery
475 Diehl Rd
Naperville, IL 60563
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Aortic valve regurgitation associated
with a fibrous band between the
leaflet and the aortic wall
To the Editor:
We read with great interest the article of
Nakajima and associates1 in the October
2002 issue of the Journal, “Aortic Regur-
gitation Caused by Rupture of a Well-Bal-
anced Fibrous Strand Suspending a Degen-
erative Tricuspid Aortic Valve.” They
showed a unique case with aortic valve
regurgitation. The well-balanced aortic val-
vular apparatus shown in their case report
has not been reported previously. They in-
ferred the rupture of one the six fibrous
strands between the three aortic leaflets and
the ascending aorta as a cause of aortic
valve incompetence, because the other two
leaflets suspended by intact strands were
expected to function well.
We have seen two cases of strands in
bicuspid aortic valves. The patients were 25-
and 45-year-old men. Preoperative echocar-
diographic study of both patients showed the
presence of strands, and the related leaflet
was prolapsed toward the left ventricle in the
second case. Unfortunately, we could not get
a definite preoperative diagnosis of the pres-
ence of the strand in our first case, although
we recognized it retrospectively. However,
we were able to point out the presence in the
second case before operating (Figure 1), and
operative findings endorsed the preoperative
study. The strands were not ruptured in both
cases. The proximal ends of the strands were
situated on the conjoined portion of the fused
leaflets, and the distal ends were around the
sinotubular junction of the ascending aorta.
The left and right leaflets were fused in both
cases. The patients underwent aortic valve
replacement. The resected leaflets showed a
mucinous degeneration without inflamma-
tion. Our operative and pathologic findings
were similar to those in previous reports of
such strands.
Embryologically, the aortic valve is
formed through truncus ridge elaboration
in the truncus arteriosus. We therefore hy-
pothesize that these strands may be embry-
ogenic remnants during the semilunar cusp
formation process of the aortic valve.2 Na-
kajima and associates1 mentioned that rup-
ture of a well-balanced fibrous strand sus-
pending a degenerative tricuspid aortic
valve was the cause of aortic regurgitation.
They confirmed that the well-balanced fi-
brous strands existed between the intact
leaflets and the ascending, suspending two
leaflets with a good coaptation. They lik-
Figure 1. Preoperative echocardiography. A, Long-axis view of left ventricular outflow shows strand between
leaflet and ascending aorta (arrows). B, Short-axis view of ascending aorta also shows strand as small
high-echoic shadow in ascending aorta (wedges).
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